102 related articles for article (PubMed ID: 11018806)
1. Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide.
Castro RR; Serra SM; Nóbrega AC
Arq Bras Cardiol; 2000 Sep; 75(3):205-13. PubMed ID: 11018806
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Braz J Med Biol Res; 2002 Jun; 35(6):685-9. PubMed ID: 12045833
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.
Nóbrega AC; dos Reis AF; Moraes RS; Bastos BG; Ferlin EL; Ribeiro JP
Clin Auton Res; 2001 Feb; 11(1):11-7. PubMed ID: 11503945
[TBL] [Abstract][Full Text] [Related]
4. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects.
Sant'anna ID; de Sousa EB; de Moraes AV; Loures DL; Mesquita ET; da Nóbrega AC
Clin Sci (Lond); 2003 Aug; 105(2):161-5. PubMed ID: 12627998
[TBL] [Abstract][Full Text] [Related]
5. Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease.
Castro RR; Serra SM; Porphirio G; Mendes FS; Oliveira LP; Nóbrega AC
Int J Cardiol; 2006 Feb; 107(1):138-9. PubMed ID: 16337518
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats.
Soares PP; da Nóbrega AC; Ushizima MR; Irigoyen MC
Auton Neurosci; 2004 Jun; 113(1-2):24-31. PubMed ID: 15296792
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
[TBL] [Abstract][Full Text] [Related]
8. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans.
Nóbrega AC; Carvalho AC; Bastos BG
Braz J Med Biol Res; 1996 Nov; 29(11):1461-5. PubMed ID: 9196546
[TBL] [Abstract][Full Text] [Related]
9. Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine.
Serra SM; Costa RV; Bastos BG; Bousquet Santos K; Ramalho SH; da Nóbrega AC
Arq Bras Cardiol; 2001 Apr; 76(4):279-84. PubMed ID: 11323731
[TBL] [Abstract][Full Text] [Related]
10. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
[TBL] [Abstract][Full Text] [Related]
11. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
Castro RRT; Porphirio G; Xavier SS; Moraes RS; Ferlin EL; Ribeiro JP; da Nóbrega ACL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28715142
[TBL] [Abstract][Full Text] [Related]
13. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study.
Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure.
Serra SM; Costa RV; Teixeira De Castro RR; Xavier SS; Nóbrega AC
J Card Fail; 2009 Mar; 15(2):124-9. PubMed ID: 19254671
[TBL] [Abstract][Full Text] [Related]
15. Pyridostigmine-Induced Bradycardia in Patient With MuSK-Ab-Positive Myasthenia Gravis and Alopecia Universalis.
Nazari F; Abdi S
J Clin Neuromuscul Dis; 2017 Sep; 19(1):49-50. PubMed ID: 28827491
[No Abstract] [Full Text] [Related]
16. Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans.
Zimerman LI; Liberman A; Castro RR; Ribeiro JP; Nóbrega AC
Braz J Med Biol Res; 2010 Feb; 43(2):211-6. PubMed ID: 20084332
[TBL] [Abstract][Full Text] [Related]
17. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine.
Alhalel A; Ziv I; Versano D; Ruach M; Alkalay M; Almog S; Izraeli S; Glovinsky J
Aviat Space Environ Med; 1995 Nov; 66(11):1037-40. PubMed ID: 8588791
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein.
Santos-Almeida FM; Girão H; da Silva CA; Salgado HC; Fazan R
Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H101-7. PubMed ID: 25416192
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Heart; 2004 Oct; 90(10):1119-23. PubMed ID: 15367503
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress.
Nóbrega AC; Carvalho AC; Santos KB; Soares PP
Clin Auton Res; 1999 Feb; 9(1):11-6. PubMed ID: 10212743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]